BAT nicotine inhaler licensed as medicinal product in UK

LONDON, Sept 12 (Reuters) - A new nicotine inhaler to be sold by a unit of British American Tobacco has been licensed in the UK as a medicinal product, marking the arrival of a new competitor in the fast-growing electronic cigarette market.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.